IS5176A - Eyðniveiru-próteasa tálmar - Google Patents

Eyðniveiru-próteasa tálmar

Info

Publication number
IS5176A
IS5176A IS5176A IS5176A IS5176A IS 5176 A IS5176 A IS 5176A IS 5176 A IS5176 A IS 5176A IS 5176 A IS5176 A IS 5176A IS 5176 A IS5176 A IS 5176A
Authority
IS
Iceland
Prior art keywords
protease inhibitors
antiviral protease
antiviral
inhibitors
protease
Prior art date
Application number
IS5176A
Other languages
English (en)
Icelandic (is)
Inventor
F. Albizati Kim
Reich Siegfried
D. Varney Michael
E. Zhang Kanyin
Kobayashi Takuo
Original Assignee
Agouron Pharmaceuticals, Inc.
Japan Tobacco Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharmaceuticals, Inc., Japan Tobacco Inc. filed Critical Agouron Pharmaceuticals, Inc.
Publication of IS5176A publication Critical patent/IS5176A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/22Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/14Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/36Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/02Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
IS5176A 1997-03-13 1999-09-10 Eyðniveiru-próteasa tálmar IS5176A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81595197A 1997-03-13 1997-03-13
PCT/US1998/004735 WO1998040357A2 (en) 1997-03-13 1998-03-12 Hiv protease inhibitors

Publications (1)

Publication Number Publication Date
IS5176A true IS5176A (is) 1999-09-10

Family

ID=25219265

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5176A IS5176A (is) 1997-03-13 1999-09-10 Eyðniveiru-próteasa tálmar

Country Status (35)

Country Link
EP (1) EP0970055A2 (ko)
JP (1) JP2001516350A (ko)
KR (1) KR100511089B1 (ko)
CN (1) CN1179948C (ko)
AP (1) AP1358A (ko)
AR (1) AR012556A1 (ko)
AU (1) AU743078B2 (ko)
BG (1) BG63540B1 (ko)
BR (1) BR9808867A (ko)
CA (1) CA2284163A1 (ko)
CO (1) CO4940496A1 (ko)
CZ (1) CZ296647B6 (ko)
EA (1) EA002378B1 (ko)
EE (1) EE04114B1 (ko)
GE (1) GEP20022764B (ko)
HR (1) HRP980112A2 (ko)
HU (1) HUP0001380A3 (ko)
IL (2) IL131870A0 (ko)
IS (1) IS5176A (ko)
MX (1) MXPA99008395A (ko)
MY (1) MY117535A (ko)
NO (1) NO315555B1 (ko)
NZ (1) NZ337706A (ko)
OA (1) OA11196A (ko)
PA (1) PA8448801A1 (ko)
PE (1) PE58799A1 (ko)
PL (1) PL192786B1 (ko)
SA (1) SA98181116B1 (ko)
SK (1) SK283636B6 (ko)
SV (1) SV1998000038A (ko)
TR (1) TR199902508T2 (ko)
TW (1) TW200517112A (ko)
UA (1) UA57772C2 (ko)
WO (1) WO1998040357A2 (ko)
ZA (1) ZA982047B (ko)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484926A (en) * 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors

Also Published As

Publication number Publication date
EP0970055A2 (en) 2000-01-12
BR9808867A (pt) 2000-07-11
NO994415D0 (no) 1999-09-10
EA199900823A1 (ru) 2000-04-24
PE58799A1 (es) 1999-07-12
NZ337706A (en) 2001-04-27
WO1998040357A3 (en) 1998-11-26
HRP980112A2 (en) 1998-12-31
PA8448801A1 (es) 2000-05-24
EE9900416A (et) 2000-04-17
SK283636B6 (sk) 2003-11-04
AR012556A1 (es) 2000-11-08
TW200517112A (en) 2005-06-01
SV1998000038A (es) 1999-02-15
AP9901648A0 (en) 1999-09-30
PL335672A1 (en) 2000-05-08
WO1998040357A2 (en) 1998-09-17
IL131870A (en) 2006-04-10
CZ296647B6 (cs) 2006-05-17
CA2284163A1 (en) 1998-09-17
AU743078B2 (en) 2002-01-17
BG63540B1 (bg) 2002-04-30
KR100511089B1 (ko) 2005-08-31
SK122299A3 (en) 2000-05-16
CN1253548A (zh) 2000-05-17
AP1358A (en) 2004-12-03
CN1179948C (zh) 2004-12-15
CZ319199A3 (cs) 2000-06-14
ZA982047B (en) 1998-09-28
MXPA99008395A (es) 2003-08-12
SA98181116B1 (ar) 2006-10-04
EA002378B1 (ru) 2002-04-25
NO994415L (no) 1999-11-10
IL131870A0 (en) 2001-03-19
UA57772C2 (uk) 2003-07-15
NO315555B1 (no) 2003-09-22
KR20000076236A (ko) 2000-12-26
EE04114B1 (et) 2003-08-15
HUP0001380A2 (hu) 2000-09-28
BG103727A (en) 2000-04-28
GEP20022764B (en) 2002-08-26
TR199902508T2 (xx) 2000-02-21
JP2001516350A (ja) 2001-09-25
AU6457598A (en) 1998-09-29
CO4940496A1 (es) 2000-07-24
OA11196A (en) 2003-05-21
MY117535A (en) 2004-07-31
HUP0001380A3 (en) 2001-12-28
PL192786B1 (pl) 2006-12-29

Similar Documents

Publication Publication Date Title
NO995433D0 (no) Protease-inhibitorer
NO20012980D0 (no) Proteaseinhibitorer
DE69841226D1 (de) Mehrfach substituierte protease Varianten
NO20006718D0 (no) Proteaseinhibitorer
PT936912E (pt) Inibidores de cisteina protease
DK1004669T3 (da) Hidtil ukendte differentieringsinhibitor
DE69823178D1 (de) Serine protease inhibitoren
DK1027332T3 (da) Hidtil ukendte lactametalloproteaseinhibitorer
DK0958287T3 (da) Sulfamidmetalloprotease-inhibitorer
NO996578D0 (no) Urokinase-inhibitorer
NO995434L (no) Proteaseinhibitorer
NO995435D0 (no) Protease-inhibitorer
NO20003256D0 (no) ACE inhibitor-MMP inhibitor kombinasjoner
NO995268D0 (no) Proteaseinhibitorer
IS5176A (is) Eyðniveiru-próteasa tálmar
MA26429A1 (fr) Inhibiteurs de protease
FI971467A0 (fi) Saekerhetshandtag till trappstege
FI973630A0 (fi) Skaft till golfklubba
FI973202A0 (fi) Justerbar skjutdel till sittvagn/barnvagn
FI973001A0 (fi) Glidskydd till vinterskodon
FI972803A0 (fi) Vindhjul till vindkraftverk
FI972615A0 (fi) Bromsarrangemang till nedstigningsbroms foer lyftbord
FI972152A0 (fi) Smyghjul till moebel
FI971798A0 (fi) RAM- eller stoedbalk till lyftmekanism
FI971309A0 (fi) Bakskiva till ostpresskar